Introduction
Multiple sclerosis (MS) is an unpredictable disease of the central nervous system which disrupts the communication between the brain and other parts of the body. Multiple sclerosis (MS) can range from relatively benign to somewhat disabling and devastating symptoms. Some of today approved drugs to treat multiple sclerosis include Novantrone (mitoxantrone), teriflunomide, dimethyl fumarate, copolymer I (Copaxone) and forms of beta interferon. Steroids are used to reduce the duration and severity of attacks in some patients suffering from Multiple sclerosis. Exercise and physical therapy can help to preserve remaining function. Various aids such as foot braces, canes, and walkers are of use to help patients to remain independent and mobile. Thus far, there is as yet no cure for multiple sclerosis while millions of people are suffering from this disease. Epstein-Barr virus (EBV), a herpes virus, is a primary cause of infectious mononucleosis (IM) and associated with several malignancies including such as Hodgkin lymphoma, non-Hodgkin lymphoma, Burkitt lymphoma and other. Epidemiological, molecular virology and other [1]- [6] studies have been able to establish EBV as a risk factor for the development of multiple sclerosis (MS) and provided some evidence that the pathogenesis of multiple sclerosis might involve a response to an EBV infection. Still, the cause of Multiple sclerosis is not identified.
Material and methods

Definitions
Definition. Bernoulli random variable
Let t=+1, …, +N denote an individual Bernoulli trial each with constant success probability p. Let N denote the number of independent Bernoulli trials (the size of a random sample or of the population).
Definition. The 2x2 table
Let A t denote a Bernoulli distributed random variable. Let p(A t ) denote the probability of A t . Let B t denote a Bernoulli distributed random variable. Let p(B t ) denote the probability of B t . Let p(a t )=p(A t ∩B t ) denote joint distribution of A t and B t . Let p(b t )=p(A t ∩B t ) denote joint distribution of A t and B t . Let p(c t )=p(A t ∩B t ) denote joint distribution of A t and B t . Let p(d t )=p(A t ∩B t ) denote joint distribution of A t and B t . In general, it is p(a t )+ p(b t ) +p(c t ) +p(d t ) = 1. Thus far, the relationships before are expressed in the 2 × 2 table (Table ) . 
Thus far, let A=N×p(A t ) denote the expectation value. Let A=N-A=N×(1-p(A t )) denote the expectation value. Let B=N×p(B t ) denote the expectation value. Let B=N-B=N×(1-p(B t )) denote the expectation value. Let a=N×p(a t )=N×p(A t ∩B t ) denote the expectation value. Let b=N×p(b t )=N×p(A t ∩B t ) denote the expectation value. Let c=N×p(c t )=N×p(A t ∩B t ) denote the expectation value. Let d=N×p(d t ) =N×p(A t ∩B t ) denote the expectation value. Let N=a+b+c+d = N×( p(a t )+ p(b t ) +p(c t ) +p(d t )) denote the size of the sample or the size of the population. Let A = a+b denote the expectation value of the condition (i. e. a risk factor, the verum population, the exposed group). Let A = c+d denote the expectation value of the non-condition (i. e. the non-exposed group, the control population). Let B=a+c denote the expectation value of the conditioned. Let B=b+d denote the expectation value of the not conditioned. Thus far, the relationships before are expressed in the 2 × 2 table (Table ) . In epidemiology and statistics, relative risk (RR) is the ratio of the probability of an event a occurring under conditions of being exposed to (a+b), the non-exposed to the probability of c occurring under conditions of being exposed to (c+d), the non-exposed group. The relative risk (RR) is a widely used measure of association in epidemiology. A risk ratio RR(A,B) < 1 suggest that an exposure can be considered as being associated with a reduction in risk. A risk ratio RR(A,B) > 1 suggest that an exposure can be considered as being associated with an increase in risk.
Conditions
The following relationships are taken with friendly permission by Ilija Barukčić [10].
Definition. Conditio sine qua non relationship
Let p(A t <-B t ) denote [10] the extent to which a condition A is a conditio sine qua non of the conditioned B. The conditio sine qua non relationship is calculated as
The relationship before is expressed in the following 2 × 2 (Table ) . 
The relationship before is expressed in the following 2x2 table (Table ) . 
Definition. Conditio per quam relationship
Let p(A t ->B t ) denote [10] the extent to which a condition A is a conditio per quam of the conditioned B. The conditio per quam is calculated as
The relationship before is expressed in the following 2x2 table (Table ) . The relationship before is expressed in the following 2 × 2 table (Table ) .
Table.
Anti conditio per quam.
Conditioned B Yes
No
Definition. Conjunction A and B relationship
Let p(A t ∩B t ) denote [10] the extent to which a condition A is conjugated with the conditioned B. The conjunction is calculated as conjunction of the two events
Definition. Exclusion relationship
Let p(A t ∩B t ) denote [10] the extent to which a condition A exculdes the conditioned B and vice versa. The exculsion relationship (Sheffer stroke) named after Henry M. Sheffer is written as a vertical bar or an upwards arrow and calculated as (7) or (8) The relationship before is expressed in the following 2 × 2 table (Table ) . 
Definition. Disjunction A or B relationship
Let p(A t ∪B t ) denote [10] the extent to which the condition A or the conditioned B are given. The inclusive disjunction also known as alternation is calculated as (9) or (10) The relationship before is expressed in the following 2x2 table (Table ) . The relationship before is expressed in the following 2 × 2 table (Table ) . Table. Exclusion.
Conditioned B Yes
Definition. Equivalence of A and B relationship
Let p(A t <=>B t ) denote [10] the extent to which a condition A or the conditioned B are equivalent. The inclusive disjunction also known as alternation is calculated as (12) The relationship before is expressed in the following 2x2 table (Table ) . 
Definition. Either A or B relationship
Let p(A t >=<B t ) denote [10] the extent to which either a condition A or the conditioned B is given. The either A or B relationship can be calculated as (13 ) The relationship before is expressed in the following 2 × 2 table (Table ) . (Table ) . The data of the prevalence of IgG antibodies in serum samples from multiple sclerosis (MS) patients and healthy control subjects are viewed in the following 2 × 2 table (Table ) . 
Methods
The chi-squared distribution
The properties of the chi-squared distribution were first investigated by Karl Pearson [12] in 1900. The chi-squared distribution is a widely used probability distributions in hypothesis testing, inferential statistics or in construction of confidence intervals. In last consequence, the Chi Square with one degree of freedom is nothing but the distribution of a single normal deviate squared.
The binomial proportion confidence interval
The statistical significance of deviations from a theoretically expected distribution of observations can be tested by a binomial test. For large samples, the binomial distribution is well approximated by convenient Pearson's chi-squared test. The above relationships are grounded on the assumption, that the number of successes X out of a sample of n observations is equal to X=N. In general, let df1 l denote the degrees of freedom 1 of the f-distribution for the lower confidence bound. Thus far, it is df1 lower = 2(N-X+1). Under conditions where N=X the proportion of success is p(X/N)=1, the is then df1 lower = 2. Let df2 lower denote the degrees of freedom 2 of the f-distribution for the lower confidence bound. In particular, we obtain df2 lower = 2×X. Under conditions where N=X the proportion of success is p(X/N)=1 and df2 lower = 2×N. The exact one-sided lower confidence interval with confidence level 1 -alpha for the proportion of successes p(X/N)=1 can be calculated [13] as (14) Example.
The F-Value for X=N=271 (Alpha = 0.05) is F df1=2, df2=542, Alpha=0.05 = 3.01235141. The exact one-sided lower confidence bound for the proportion of successes p(X/N)=1 can be calculated as (15) In other words, we assume that the p in the population is greater or equal to 0,989006512. Furthermore, the one-sided lower confidence interval with confidence level 1 -alpha for the proportion of successes p(X/N)=1, reflects a significance level of i. e. alpha = 0.05, and can be calculated for N > 50 approximately 
Causal relationship k
The mathematical formula of the causal relationship k was used to determine the cause-effect relationship between Epstein-Barr virus (EBV) infections and multiple sclerosis (MS). According to Barukčić [14] , the causal relationship k is calculated as (17) The relationship before is expressed in the following 2 × 2 table (Table ) . . We have now reached some very important conclusions about Pearson's account for causality. Due to Pearson, there is no causation at all. Pearson published a lot of mathematical formulas. But neither Pearson's correlation coefficient nor his mean square contingency can be regarded as the mathematical formula of the causal relationship k. In particular, Pearson failed to derive a mathematical formula of the causal relationship and to provide a self-consistent proof of a mathematical formula of the causal relationship.
1 0
Statistical analysis.
Data were analyzed using Microsoft Excel version 14.0.7166.5000 (32-Bit) software (Microsoft GmbH, Munich, Germany). The mathematical formula of the causal relationship k and the chi-square distribution were applied to determine the significance of causal relationship between EBV and multiple sclerosis (MS). A p value of < 0.05 was considered significant.
Results
Clinical characteristics
Wandinger [11] et al. examined 108 MS patients from the Department of Neurology (University of Lübeck School of Medicine). All patients were examined independently by two neurologists and had a diagnosis of clinically definite MS. Kurtzke's functional systems and Expanded Disability Status Scale (EDSS) were used to grade the physical disability.
EBV seropositivity
The viral status was classified by following serologic definitions. Wandinger 
Epstein Barr virus (EBV) is a conditio sine qua non of multiple sclerosis (MS)
A hypothesis test is used to distinguish between the null hypothesis and the alternative hypothesis.
Theorem 1.
Null hypothesis: EBV is a condition sine qua non of multiple sclerosis (MS) Alternative hypothesis:
EBV is not a condition sine qua non of multiple sclerosis (MS). Significance level (Alpha) below which the null hypothesis will be rejected: 0.05
Proof by a statistical hypothesis test.
The data of the prevalence of IgG antibodies in serum samples from multiple sclerosis (MS) patients and healthy control subjects are viewed in the following 2 × 2 table (Table ) . The proportion of successes p(A t <-B t ) of the condition sine qua non relationship in the sample or the test statistic can be calculated defined before as 
The critical value p lower calculated as
The critical value p lower = 0,989006512 and is less than the proportion of successes p(A t <-B t )=1 as obtained from the observations (the significance level alpha = 0.05).
Conclusio.
We cannot reject the null hypothesis in favor of the alternative hypotheses.
Epstein Barr virus (EBV) is a conditio sine qua non of multiple sclerosis (MS).
In other words, without an infection with Epstein Barr virus (EBV) no development of multiple sclerosis (MS).
Quod erat demonstrandum. 
Epstein Barr virus (EBV) is the cause of multiple sclerosis (MS)
A two tail Chi square of 11,2664020209 is equivalent to a p-value of 0,0004251570.
Conclusio.
The value of the test statistic (k obtained or Chi square calculated) is 11,2664020209 and exceeds the critical Chi square value of 3,841458821. Consequently, we reject the null hypothesis (H 0 ) and accept the alternative hypothesis (H A ).
There is a highly significant causal relationship between Epstein Barr virus (EBV) and multiple sclerosis (k=+0,2038956576, p-value 0,0004251570).
Quod erat demonstrandum.
Discussion
Today, the etiology of multiple sclerosis (MS) is largely unknown but multiple sclerosis (MS) is rare among individuals without serum EBV antibodies. In addition, our study confirms a conditio sine qua non relationship between EBV infection and multiple sclerosis (MS). In other words, without an infection with Epstein-Barr virus (EBV) no development of multiple sclerosis (MS) (significance level alpha = 0.05). We observed a highly significant causal relationship between Epstein-Barr virus (EBV) and multiple sclerosis (k=+0,203895658, p value = 0,000425157). A particular aspect of our study is the identification of Epstein-Barr virus (EBV) as the cause of multiple sclerosis.
Since without an infection by Epstein-Barr virus (EBV) no multiple sclerosis develops and due to the fact that there is a highly significant causal relationship between Epstein-Barr virus (EBV) and multiple sclerosis, we are allowed to deduce that Epstein-Barr virus (EBV) is not only a cause but the cause of multiple sclerosis (MS).
Conclusions
A particular aspect of our study is the identification of Epstein-Barr virus (EBV) as the cause of multiple sclerosis (MS). Finally, the cause of multiple sclerosis is identified.
